JUVÉDERM VOLUMA XC is the latest craze in the world of fillers, and for a very good reason. It is the first and only injectable gel that is FDA-approved to instantly correct age-related volume loss in the cheek area for people over 21. It adds volume, creating contour and lift for up to two years with optimal treatment.
VOLUMA XC is the most recent innovation among the JUVÉDERM family of hyaluronic acids. The suffix XC denotes that it has built-in lidocaine in the syringe for making this a near pain-free procedure. HA, or hyaluronic acid, is a naturally occurring sugar that is present in our body. In the skin, HA helps in hydration by holding in water, as well as acting as a cushioning agent.
JUVÉDERM VOLUMA XC, though a HA filler, the similarities end at the chemical composition. It differs from all other fillers in the areas injected, the type of correction sought, longevity of the product and several more. A special process of cross linking has made this product last as long as two years in majority of patients. Traditionally, fillers are injected along the smile lines, or naso-labial folds, pre-jowl area, or the marionette lines, or the hollowness of the cheeks. These injections are given just under the skin or slightly deeper into the subcutaneous fat. Instead, JUVÉDERM VOLUMA XC is injected deep, close to the cheek bone. It acts to tack the deep tissues of the midface, reducing the sag in the front of the cheeks. In many, the need to inject the smile lines is reduced and the tired looking lid-cheek junction looks more rejuvenated. Even if there is a need to inject the naso-labial folds with JUVÉDERM, the amount of the product will be a lot less.
JUVÉDERM VOLUMA XC has been used all over Europe since 2005 and has established excellent track record of satisfaction and safety. The FDA cleared the use of this product in the U.S. only toward the end of 2013. This has now become the most desired filler requested by the consumers. The studies done in the U.S. found the following results:
- 86% of subjects had at least a 1-point improvement in their cheek fullness 6 months after treatment
- Subjects rated themselves as looking an average of 5 years younger 6 months after their last treatment
- More than 75% of subjects reported an improvement in their overall satisfaction with their facial appearance at 2 years after their last treatment.
If you’re in the San Antonio, Texas area, consider making an appointment for a free consultation to see if you are a candidate for this treatment. Allergan, the maker of JUVÉDERM VOLUMA XC, is giving financial incentives if the procedure is completed by the end of April, when combined with Botox treatment.